Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells

Bombesin-like Peptides have been implicated as autocrine growth factors influencing the pathogenesis and progression of some human lung carcinoma cells. To determine the pharmacologic and structural properties of the bombesin receptors expressed in human lung carcinoma cells, cDNA clones encoding a human gastrin-releasing peptide receptor (GRP-R) and a pharmacologically distinct neuromedin-B preferring bombesin-receptor (NMB-R) were isolated from a human small cell lung carcinoma cell line (NCI-H345). After expression in Xenopus oocytes, a GRP-R-specific antagonist was effective in blocking responses elicited from the cloned GRP-R, but not the NMB-R. Both GRP-R and NMB-R mRNA expression was detected at varying levels in a panel of human lung Cancer cell lines. These results indicate heterogeneity of Bombesin Receptor subtypes exists in human lung carcinoma cells and should be considered in the design of Bombesin Receptor antagonists intended to inhibit tumor cell growth.